Lenvacent 10 mg (Lenvatinib) Capsules

Lenvacent 10 contains Lenvatinib, a targeted anticancer medicine that works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By interfering with these pathways, it may help slow disease progression in selected cancer types.

Therapeutic Uses:

• Management of differentiated thyroid cancer that is locally recurrent or metastatic and progressive.
• Treatment of unresectable hepatocellular carcinoma (liver cancer) in appropriate adult patients.
• Used in combination therapy for certain cases of advanced renal cell carcinoma (kidney cancer).
• May be prescribed with other anticancer agents for the treatment of selected patients with advanced endometrial carcinoma.
• Helps inhibit tumor growth and reduce the spread of cancer cells under specialist supervision. 

Ingredients & Composition

Active Ingredient:

• Lenvatinib Mesylate USP

Strength:

• Equivalent to Lenvatinib 10 mg

Dosage Form:

• Capsule

Composition:

Each capsule contains:

• Lenvatinib (as Lenvatinib Mesylate) USP equivalent to 10 mg
• Pharmaceutical excipients q.s. to maintain capsule stability and integrity.

Lenvacent 10 should be used only under the supervision of a qualified healthcare professional experienced in cancer treatment.

Recommended Administration:

• Take the capsule exactly as prescribed by your oncologist.
• Swallow the capsule whole with water.
• It may be taken with or without food.
• Try to take the medicine at the same time each day to maintain consistent drug levels.

Missed Dose:

• If a dose is missed and there are more than 12 hours before the next scheduled dose, take it as soon as remembered.
• If less than 12 hours remain before the next dose, skip the missed dose and continue with the regular schedule.
• Do not take a double dose to compensate for a missed dose.

Important Administration Instructions:

• Do not crush, chew, or open the capsules unless specifically instructed by a healthcare professional.
• The dosage may vary depending on the type of cancer, treatment response, and individual patient factors.
• Dose adjustments or temporary interruption of treatment may be required if significant adverse reactions occur.
• Regular monitoring of blood pressure, liver function, kidney function, and other clinical parameters may be necessary during therapy.

Note: The exact dosing regimen should always follow the prescribing physician's recommendation and the approved prescribing information for the specific indication.